InvestorsHub Logo
Followers 922
Posts 63070
Boards Moderated 0
Alias Born 12/27/2000

Re: RIGATONI post# 330538

Monday, 02/25/2019 3:21:08 PM

Monday, February 25, 2019 3:21:08 PM

Post# of 385426
TRGM Email response (I have another email in as well with a different question too btw)

Hello Scott,
Thank you for your continued support of our company. The Company is alive and recovering from significant business and management changes that have occurred overt the past 4 years.

As the Company continues to grow and stabilize, we will file reports as required for trading common stock on the OTC Pink Sheets. The details of this process are still being worked on, but more information will be released to the public as soon as possible. We continue to build our brand awareness in the pharmacy, physician and direct to consumer markets and would appreciate any support from our shareholder base. You can learn more and help support our Company by sharing our products with your network of friends and family.

Sleep Management - http://www.sentrapm.com/
Pain Management - http://www.theramine.info/
Weight Management - http://www.apptrim.com/
Sinus and Respiratory Health - http://www.clearwayz.com/
Blood pressure support - http://www.hypertensa-adv.com/


We will be using press releases to communicate financial filings at some point in the near future. As of now our public releases are put out on the company website and the company Linked In page as part of our cost containment strategy.

If you have additional questions please call (310) 474-9809 ext 177.

thank you,


MARCUS CHARUVASTRA

Managing Director

Targeted Medical Pharma, Inc.

2980 Beverly Glen Circle, Suite 100

Los Angeles, CA 90077

310-474-9809 ext 177 (ph)

323-677-5466

marcusch@tmedpharma.com

www.tmedpharma.com

DD makes the charts, the charts don't make the DD.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.